MVA-LACK as a safe and efficient vector for vaccination against leishmaniasis

Microbes and Infection
E Pérez-JiménezMariano Esteban

Abstract

An optimal vaccine against leishmaniasis should elicit parasite specific CD4+ and cytotoxic CD8+ T cells. In this investigation, we described a prime/boost immunization approach based on DNA and on poxvirus vectors (Western Reserve, WR, and the highly attenuated modified vaccinia virus Ankara, MVA), both expressing the LACK antigen of Leishmania infantum, that triggers different levels of specific CD8+ T cell responses and protection (reduction in lesion size and parasitemia) against L. major infection in mice. A prime/boost vaccination with DNA-LACK/MVA-LACK elicits higher CD8+ T cell responses than a similar protocol with the replication competent VV-LACK. Both CD4+ and CD8+ T cells were induced by DNA-LACK/MVA-LACK immunization. The levels of IFN-gamma and TNF-alpha secreting CD8+ T cells were higher in splenocytes from DNA-LACK/MVA-LACK than in DNA-LACK/VV-LACK immunized animals. Moreover, protection against L. major was significantly higher in DNA-LACK/MVA-LACK than in DNA-LACK/VV-LACK immunized animals when boosted with the same virus dose, and correlated with high levels of IFN-gamma and TNF-alpha secreting CD8+ T cells. In DNA-LACK/MVA-LACK vaccinated animals, the extent of lesion size reduction ranged from 65 to 92% an...Continue Reading

References

Nov 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·G Sutter, B Moss
Jan 1, 1991·Research in Immunology·R M LocksleyM D Sadick
Jan 1, 1989·Archives of Virology·W AltenburgerJ Altenburger
Mar 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J F RodriguezM Esteban
Apr 28, 1995·Science·E MougneauN Glaichenhaus
Mar 5, 1993·Science·S L ReinerR M Locksley
Jun 24, 1998·Proceedings of the National Academy of Sciences of the United States of America·M SedegahS L Hoffman
Mar 17, 2000·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·A L BerthoS G Coutinho
Mar 31, 2000·Immunology Today·I A Ramshaw, A J Ramsay
Mar 31, 2001·Transactions of the Royal Society of Tropical Medicine and Hygiene·Z BabalooM B Eslami
Aug 4, 2001·The American Journal of Pathology·F ChenX Shi
Jun 12, 2002·Transactions of the Royal Society of Tropical Medicine and Hygiene·I CruzUNKNOWN Spanish HIV-Leishmania Study Group
Dec 3, 2002·The Biochemical Journal·Sanjay GhoshSamit Adhya

❮ Previous
Next ❯

Citations

Jun 11, 2010·Journal of Virology·Susana GuerraMariano Esteban
Feb 21, 2013·Transactions of the Royal Society of Tropical Medicine and Hygiene·Wilson MayrinkGeorge Luiz Lins Machado-Coelho
Aug 22, 2007·Journal of Biomedicine & Biotechnology·Eric Dumonteil
Apr 9, 2015·Viruses·Lucas Sánchez-SampedroMariano Esteban
Sep 3, 2009·Expert Review of Vaccines·Charani Ranasinghe, Ian A Ramshaw
Jul 2, 2008·Expert Opinion on Drug Delivery·Sudipta Bhowmick, Nahid Ali
Nov 26, 2015·Acta Tropica·Vívian Tamietti MartinsEduardo Antonio Ferraz Coelho
Oct 13, 2015·Parasite Immunology·Daniela Pagliara LageEduardo Antonio Ferraz Coelho
Aug 19, 2007·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·A Crampton, T Vanniasinkam
Jun 6, 2009·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Sara E Crager, Matt Price
Oct 4, 2012·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Fatemeh GhaffarifarHajar Ziaei Hezarjaribi
May 28, 2011·International Immunopharmacology·Rajeev Nagill, Sukhbir Kaur
Apr 2, 2013·Experimental Parasitology·Hajar Ziaee HezarjaribiOgholniaz Jorjani
Aug 20, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·P M Kaye, T Aebischer
Jan 2, 2007·Reviews in Medical Virology·Richard Kennedy, Gregory A Poland
Aug 8, 2015·The Cochrane Database of Systematic Reviews·Urbà GonzálezJorge Alvar
Sep 30, 2010·Transactions of the Royal Society of Tropical Medicine and Hygiene·Shiva Raj AdhikariM Mahmud Khan
Jan 3, 2013·Medical and Veterinary Entomology·K IngenloffR M Poché
Jan 17, 2020·PLoS Neglected Tropical Diseases·Anne L WilsonSteve W Lindsay
Mar 8, 2020·Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]·Danielle Soares de Oliveira Daian E SilvaFlávio Guimarães Da Fonseca

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.